Premium
Sarepta Therapeutics Inc New (SRPT)
NASDAQ
Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Sarepta Therapeutics is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for deve... Sarepta Therapeutics is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of Sarepta's product candidates are at an early stage of development. Show more
– Treatment with ELEVIDYS corresponded with increases on the North Star Ambulatory Assessment (NSAA) at one year in crossover patients, while the study remained blinded – MRI results at two years...
– Preliminary total net product revenue of $638.2 million for the fourth quarter and $1.79 billion for full-year 2024, exceeding full-year guidance by over $100 million – Preliminary ELEVIDYS net...
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will present at the 43rd Annual J.P. Morgan Healthcare...
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on December 31, 2024 (the “Grant Date”) that were previously approved...
– Sarepta anticipates filing for accelerated approval of SRP-9003 in 2025 Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -4.415 | -3.71164354771 | 118.95 | 119.436 | 113.38 | 1021642 | 116.63781585 | CS |
| 4 | -6.9 | -5.68205212665 | 121.435 | 129.84 | 113.38 | 862412 | 119.4732318 | CS |
| 12 | -18.4649 | -13.8833938973 | 132.9999 | 138.81 | 102.155 | 979855 | 120.53788086 | CS |
| 26 | -31.455 | -21.5459963011 | 145.99 | 146.38 | 102.155 | 941722 | 125.9241524 | CS |
| 52 | -5.965 | -4.95020746888 | 120.5 | 173.1 | 102.155 | 1149864 | 131.31131226 | CS |
| 156 | 44.765 | 64.1608141035 | 69.77 | 173.1 | 55.25 | 1161784 | 115.66336788 | CS |
| 260 | -3.525 | -2.98576994748 | 118.06 | 181.83 | 55.25 | 1135527 | 110.05888857 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
